Browse by Poster Presenter

Type here to filter the list

G
Gabet, Amélie

Santé Publique France
(P-178) Patterns of Antihypertensive Drugs Use After Primary Stroke in the General Population
Amélie Gabet
Favorite
Gadalla, Shahinaz

National Cancer Institute
(P-623) Generating Hypotheses About Never-smoking Lung Cancer Risk Factors Using Large Primary Care Databases
Shahinaz Gadalla
Favorite
Gaddini, Andrea

Agency for Public Health, Lazio Region
(P-480) From Contact Coverage to Effective Coverage of Community Care for Patients with Severe Mental Disorders: A Real-world Investigation from Italy
Andrea Gaddini
Favorite
Gagne, Myriam

St. Michael's Hospital, affiliated with the University of Toronto
(P-284) High Adherence and Sustained Virologic Response Among Vulnerable People Initiating an Hcv Treatment at a Community-based Nurse-led Clinic: A Cohort Study
Myriam Gagne
Favorite
Gaillard, Philippe

Auburn University
(P-441) Risks of Cardiovascular and Kidney Events Associated with Proton Pump Inhibitor Use Among Medicare Beneficiaries: A Retrospective New User Cohort Study
Philippe Gaillard
Favorite
Galea, Francesca

Janssen-Cilag Limited, High Wycombe, United Kingdom
(P-377) Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
Francesca Galea
Favorite
Gallagher, Kerrin

HealthCore, Inc.
(P-543) The Incidence Rates of Hepatobiliary Diseases Among Non-alcoholic Steatohepatitis Patients Stratified by fibrosis-4 (FIB-4) Index for Liver Fibrosis
Kerrin Gallagher
Favorite
Galvão, taís Freire

Faculty of Pharmaceutical Sciences, State University of Campinas/Brazil
(P-488) Estimates of Paracetamol Poisoning in Brazil: Analysis of Official Records
taís Freire Galvão
Favorite
Gamon, Veronica

Center for Public Health Research (CSISP-FISABIO)
(P-398) Treatment Patterns and Appropriateness of Antipsychotic Prescriptions in Patients with Schizophrenia
Veronica Gamon
Favorite
GAO, Le

University of Hong Kong
(P-007) Association Between the Use of Mood Stabilizers and Risk of Trauma Among Patients with Bipolar Disorder
Le GAO
Favorite
Gao, Shiyao
(P-243) Healthcare Resource Use in a US Claims Database During the Early Period of the COVID-19 Pandemic
Shiyao Gao
Favorite
Garcia Rodriguez, Luis
(P-065) Safety of Rivaroxaban in First-time Users Treated for Deep Vein Thrombosis and Pulmonary Embolism
Luis Garcia Rodriguez
Favorite
(P-250) Lessons from a Post-authorisation Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Practice in Four Countries
Luis Garcia Rodriguez
Favorite
(P-252) Safety and Effectiveness of Rivaroxaban in First-time Users with Non-valvular Atrial Fibrillation in Routine Practice
Luis Garcia Rodriguez
Favorite
(P-314) Time Trends in Patient Characteristics of New Rivaroxaban (RVX) Users with Atrial Fibrillation (AF) Across Four Countries
Luis Garcia Rodriguez
Favorite
Garcia Serpa Osorio de Castro, Claudia

FUNDA��O OSWALDO CRUZ
(P-465) Avoidable Public Expenditures with Selected Antineoplastic Drugs for Breast Cancer in Brazil
Claudia Garcia Serpa Osorio de Castro
Favorite
GARCIA-SEMPERE, ANIBAL

FISABIO
(P-369) Patterns of Prescription and Co-prescription of Opioids and Benzodiazepines in the Period 2010 to 2018: A Real-world, Population-based Study
ANIBAL GARCIA-SEMPERE
Favorite
Gardarsdottir, Helga

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
(P-092) Primary Non-adherence in Primary Care in the Netherlands
Helga Gardarsdottir
Favorite
Garg, Mahek

University of Florida
(P-493) Comparison and Contrast of Antibiotic Utilization and Outcomes in Hospital-acquired Pneumonia (HAP), Ventilated HAP (vHAP) and Ventilator Associated Pneumonia (VAP) in the United States
Mahek Garg
Favorite
Garrel, Renaud

CHU de Montpellier, Service de chirurgie ORL, F-34295 Montpellier, France
(P-125) Risk of Thyroid Cancer with the Use of GLP-1 Receptor Agonists
Renaud Garrel
Favorite
Garrelts, Alyssa

Eli Lilly and Company
(P-421) Inadequate Response Rates and Associated Factors to Psoriasis Therapies Using a Claims-based Algorithm
Alyssa Garrelts
Favorite
Garrido-Estepa, Macarena

Instituto de Investigación en Enfermedades Raras. Instituto de Salud Carlos III (ISCIII). Madrid. Spain
(P-457) Systematic Review of Prospective Pregnancy Studies in Europe: Scope for Improvement
Macarena Garrido-Estepa
Favorite
Garry, Elizabeth

Aetion, Inc
(P-280) Temporal Trends in Medication Utilization Among Hospitalized COVID-19 Patients
Elizabeth Garry
Favorite
(P-281) Examining the Evolving Pandemic: Trends in COVID-19 Severity for Hospitalized COVID-19 Patients over Time
Elizabeth Garry
Favorite
(P-384) Temporal Changes in the Baseline Patient Characteristics of COVID-19 Patients
Elizabeth Garry
Favorite
(P-514) Impact of Increasing Enrollment Requirements in Administrative Claims Data
Elizabeth Garry
Favorite
(P-616) Use of High-dimensional Propensity Scores (hdPS) in a Japanese National Claims Database
Elizabeth Garry
Favorite
Gasparini, Alessandro

Karolinska Institutet
(P-618) Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care
Alessandro Gasparini
Favorite
Gately, Robert

Optum
(P-207) Trends in Administered Medication Use Among Patients Hospitalized with COVID-19 in the United States
Robert Gately
Favorite
(P-531) Role of D-dimer on Serious Outcomes Among Patients Hospitalized with COVID-19
Robert Gately
Favorite
(P-577) Clinical Characteristics of Pediatric Patients Hospitalized with COVID-19 in an Electronic Health Record Database
Robert Gately
Favorite
Gatt, Miriam

Directorate for Health Information and Research, Malta
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Miriam Gatt
Favorite
Gatto, Nicolle

Aetion, Inc
(P-280) Temporal Trends in Medication Utilization Among Hospitalized COVID-19 Patients
Nicolle Gatto
Favorite
(P-281) Examining the Evolving Pandemic: Trends in COVID-19 Severity for Hospitalized COVID-19 Patients over Time
Nicolle Gatto
Favorite
(P-384) Temporal Changes in the Baseline Patient Characteristics of COVID-19 Patients
Nicolle Gatto
Favorite
Gauffin, Oskar

Uppsala Monitoring Centre
(P-375) Remdesivir Safety Monitoring During the COVID-19 Pandemic: A Global Review of Adverse Drug Reaction (ADR) Reporting in Vigibase
Oskar Gauffin
Favorite
Geier, Jamie

Pfizer Inc
(P-339) Methods and Practical Considerations in Use of an External Control to Assess Potential Drug Risk
Jamie Geier
Favorite
Gellad, Walid

Division of General Internal Medicine, Department of Medicine, University of Pittsburgh
(P-386) Association Between Primary Care Provider Payment Models and Adherence to Anticoagulation in a Sample of Patients with Atrial Fibrillation
Walid Gellad
Favorite
gemmi, fabrizio

Agenzia regionale di sanità della Toscana, Florence
(P-414) Utilization of Drugs Reimbursed by the Italian Healthcare Service for the Treatment of COVID19 During the First Pandemic Wave: Gender Differences in the General and Nursing Home Population of Tuscany
fabrizio gemmi
Favorite
george, lincy

ST.JAMES COLLEGE OF PHARMACEUTICAL SCIENCES,CHALAKUDY
(P-167) Assessment of Drug Related Problems at a Tertiary Care Teaching Hospital
lincy george
Favorite
George, Michael

University of Pennsylvania
(P-124) Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-based Network
Michael George
Favorite
Georgiou, Mary

GlaxoSmithKline
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Mary Georgiou
Favorite
(P-408) Nucala Exposure in Women of Childbearing Age and in Pregnant Women in US Claims Data, 2016-2019
Mary Georgiou
Favorite
Geppetti, Pierangelo

Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy
(P-472) Utilization of Anti-cgrp Monoclonal Antibodies for Migraine Prophylaxis Between 2019 and 2020 in Tuscany Region, Italy
Pierangelo Geppetti
Favorite
Gerbier, Eva

Centre Hospitalier Universitaire Vaudois
(P-475) Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data
Eva Gerbier
Favorite
Gerhard, Tobias

Rutgers Center for Pharmacoepidemiology and Treatment Science
(P-350) Overdose Risk Following Prescription Benzodiazepine Treatment in Young People
Tobias Gerhard
Favorite
(P-507) Suicide Risk in Schizophrenia Across the Lifespan
Tobias Gerhard
Favorite
Getova, Violeta

Bulgarian Drug Agency, Sofia, Bulgaria
(P-417) Awareness of Pregnant Women About the Spontaneous Adverse Drug Reaction Reporting System in Bulgaria- a Pilot Study
Violeta Getova
Favorite
Ghate, Sameer

Merck & Co.,Inc.
(P-270) Real-world Algorithms in Defining Castration Resistant Prostate Cancer in Retrospective Observational Studies
Sameer Ghate
Favorite
Ghoul, Imene

Paediatric Department, Ibn AL Haytham Hospital
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Imene Ghoul
Favorite
Gibbs, Liza

Aetion, Inc
(P-514) Impact of Increasing Enrollment Requirements in Administrative Claims Data
Liza Gibbs
Favorite
Gilles, Malcolm

Centre for Big Data Research in Health, UNSW Sydney
(P-461) Prescription Opioid Use in Australian Women of Reproductive Age from 2013 to 2020
Malcolm Gilles
Favorite
Gillezeau, Christina
(P-234) Molecular Epidemiology Study of Interferon Gamma (IFN-γ) Expression in Urothelial Bladder Cancer (UBC)
Christina Gillezeau
Favorite
Gill, Rajdeep

US Food and Drug Administration
(P-549) Benzodiazepine Use, Nonmedical Use, and Overdose in the U.S
Rajdeep Gill
Favorite
Gilpin, Katherine

Aetion, Inc.
(P-514) Impact of Increasing Enrollment Requirements in Administrative Claims Data
Katherine Gilpin
Favorite
Gilsenan, Alicia

RTI Health Solutions
(P-548) Graphical Representation of Multiple Quantitative Bias Analysis Scenarios for Unmeasured Confounding
Alicia Gilsenan
Favorite
Giner-Soriano, Maria

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol). Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès)
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Maria Giner-Soriano
Favorite
Gini, Rosa

Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Rosa Gini
Favorite
(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
Rosa Gini
Favorite
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Rosa Gini
Favorite
(P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
Rosa Gini
Favorite
(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
Rosa Gini
Favorite
(P-087) Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases
Rosa Gini
Favorite
(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
Rosa Gini
Favorite
(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
Rosa Gini
Favorite
(P-414) Utilization of Drugs Reimbursed by the Italian Healthcare Service for the Treatment of COVID19 During the First Pandemic Wave: Gender Differences in the General and Nursing Home Population of Tuscany
Rosa Gini
Favorite
(P-472) Utilization of Anti-cgrp Monoclonal Antibodies for Migraine Prophylaxis Between 2019 and 2020 in Tuscany Region, Italy
Rosa Gini
Favorite
(P-567) SIGMA Consortium: A New Era of Collaboration to Study the Safety and Effectiveness of Medical Interventions
Rosa Gini
Favorite
Ginzler, Ellen

SUNY Downstate Medical Center
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Ellen Ginzler
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Ellen Ginzler
Favorite
Giometto, Sabrina

Unit of Medical Statistics, Department of Clinical and Experimental Medicine, University of Pisa
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Sabrina Giometto
Favorite
(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
Sabrina Giometto
Favorite
(P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
Sabrina Giometto
Favorite
(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
Sabrina Giometto
Favorite
(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
Sabrina Giometto
Favorite
Giorgi, Silvano

Azienda Ospedaliera Universitaria Senese, Siena
(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
Silvano Giorgi
Favorite
Gisev, Natasa

University of New South Wales
(P-326) The Effect of Prescriber, Treatment, and Client Characteristics on Retention in Opioid Agonist Treatment: A 15-year Retrospective Cohort Study
Natasa Gisev
Favorite
(P-327) POPPY II Cohort Profile– a Population-based Linked Cohort Examining the Course and Outcomes of Prescription Opioid Use in NSW, Australia, 2003-2018
Natasa Gisev
Favorite
Gisslén, Magnus

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden
(P-371) Swedish covid-19 Investigation for Future Insights – a Population Epidemiology Approach Using Register Linkage (SCIFI- PEARL)
Magnus Gisslén
Favorite
Gladman, Dafna

University of Toronto
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Dafna Gladman
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Dafna Gladman
Favorite
Glaser, Michael

GlaxoSmithKline
(P-505) Automating Individual Case Safety Report Identification Within Scientific Literature Using Natural Language Processing
Michael Glaser
Favorite
Go, Alan

Division of Research, Kaiser Permanente Northern California
(P-428) Incidence of Angioedema After Initiation of Angiotensin-converting Enzyme Inhibitors in Adults with Heart Failure
Alan Go
Favorite
Godman, Brian

Sefako Makgatho Health Sciences University
(P-162) Key Opportunities and Future Direction for Drug Utilization Research in Africa
Brian Godman
Favorite
Goldacre, Ben

University of Oxford
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Ben Goldacre
Favorite
Goletiani, Nathalie

Alexion Pharmaceuticals, Inc
(P-431) Designing Epidemiological Studies to Estimate the Incidence of Thrombosis in Patients with Antiphospholipid Syndrome with History of Recurrent Thrombotic Events
Nathalie Goletiani
Favorite
Golozar, Asieh

Regeneron Pharmaceuticals
(P-574) Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)
Asieh Golozar
Favorite
Gomez-Lumbreras, Ainhoa

University of Utah
(P-265) Detecting Tizanidine and cyp1a2 Inhibitor Interaction Signals Using the Food and Drug Administration’s Adverse Event Reporting System
Ainhoa Gomez-Lumbreras
Favorite
Gong, Richard

Pfizer Inc.
(P-072) Deterministic Linkage of Pregnant Mothers and Their Newborns in Integrated US Insurance Claims and Electronic Health Record Data
Richard Gong
Favorite
Good, Chester

UPMC Health Plan
(P-401) Inpatient Readmission and Oral Antiplatelet Adherence for Patients with Coronary Artery Disease
Chester Good
Favorite
Goodin, Amie

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(P-101) A Pharmacovigilance Analysis of Restless Legs Syndrome Treatments and Suicidality
Amie Goodin
Favorite
Goodloe, Robert

Eli Lilly and Company
(P-243) Healthcare Resource Use in a US Claims Database During the Early Period of the COVID-19 Pandemic
Robert Goodloe
Favorite
Gordon, Caroline

Institute of Inflammation and Ageing
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Caroline Gordon
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Caroline Gordon
Favorite
Gouri, Nair

Assistant Professor, Department of Pharmacology, Faculty of Pharmacy, Ramaiah University of Applied Sciences, Bengaluru, India
(P-171) Adverse Events Associated with Remdesivir in covid-19 Patients: Evaluation of Spontaneous Reports Submitted to US FDA Adverse Event Reporting System (FAERS)
Nair Gouri
Favorite
(P-172) Tocilizumab Induced Adverse Events in covid-19 Patients: Exploration of Reports Submitted to US FDA Adverse Event Reporting System (FAERS)
Nair Gouri
Favorite
(P-173) Adverse Events in covid-19 Patients Treated with Lopinavir/ritonavir: Exploration of US FDA Adverse Event Reporting System (FAERS) Reports
Nair Gouri
Favorite
Gouverneur, Amandine
(P-125) Risk of Thyroid Cancer with the Use of GLP-1 Receptor Agonists
Amandine Gouverneur
Favorite
Goyal, Ravi

RTI Health Solutions
(P-357) Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation
Ravi Goyal
Favorite
Graber, PhD, Sereina

Department of Health Sciences, Helsana Insurance Group, Zurich, Switzerland
(P-475) Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data
Sereina Graber, PhD
Favorite
Grabner, Michael

HealthCore, Inc.
(P-421) Inadequate Response Rates and Associated Factors to Psoriasis Therapies Using a Claims-based Algorithm
Michael Grabner
Favorite
Grafton, Jane

Kaiser Permanente Washington Health Research Institute
(P-286) Identification of a Diagnostically Complex Condition, Polycystic Ovarian Syndrome, in a Population-based Cohort Using Electronic Health Record Data
Jane Grafton
Favorite
Graham, Christine

Alkermes, Inc.
(P-313) Utilizing a Structured Benefit-risk Assessment to Evaluate a Combination of Olanzapine and Samidorphan for the Treatment of Schizophrenia and Bipolar I Disorder
Christine Graham
Favorite
Grams, Morgan

Johns Hopkins Bloomberg School of Public Health
(P-618) Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care
Morgan Grams
Favorite
Gravestock, Isaac

Roche
(P-247) Impact of the COVID-19 Pandemic on Routine Clinical Management of Patients with Neurological Conditions: A Retrospective Cohort Study in UK Primary Care (CPRD)
Isaac Gravestock
Favorite
Gray, Matthew

University of Pittsburgh
(P-399) Association of Ondansetron Use and Subsequent Acute Kidney Injury in Critical Care
Matthew Gray
Favorite
Greenlee, Robert

Marshfield Clinic Research Institute
(P-563) A New United States Database for Pharmacoepidemiology Studies in Type 2 Diabetes Mellitus: The IMEDS Distributed Database
Robert Greenlee
Favorite
Gregoire, Jean-Pierre

Faculty of Pharmacy, Universite Laval
(P-284) High Adherence and Sustained Virologic Response Among Vulnerable People Initiating an Hcv Treatment at a Community-based Nurse-led Clinic: A Cohort Study
Jean-Pierre Gregoire
Favorite
Griffin, Russell

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham (UAB) Alabama
(P-430) Chronic Obstructive Pulmonary Disease and Drug-resistant Pseudomonas in Patients Hospitalized with Community-acquired Bacterial Pneumonia
Russell Griffin
Favorite
Grijalva, Carlos

Vanderbilt University Medical Center
(P-537) Temporal and Hospital-level Variation in High-dose Postpartum Opioid Prescribing After Cesarean Delivery
Carlos Grijalva
Favorite
Grimaldi, Sébastien

Ophthalmologic Center, 24/26 Boulevard Aristide Briand, 86100 Châtellerault, France
(P-471) Intravitreal Anti-vascular Endothelial Growth Factors Use in France: Cross-sectional and Longitudinal Nationwide Observational Studies
Sébastien Grimaldi
Favorite
Groenwold, Rolf

Department of Clinical Epidemiology, Leiden University Medical Center
(P-092) Primary Non-adherence in Primary Care in the Netherlands
Rolf Groenwold
Favorite
Grootendorst, Paul

University of Toronto
(P-095) Fracture Outcome Coding in Observational Osteoporosis Drug Effects Studies: A Scoping Review
Paul Grootendorst
Favorite
Gross-Goupil, Marine

CHU de Bordeaux, Bordeaux, France
(P-575) Impact of Treatment Sequence on Survival Outcome in Patients with a Second Treatment Line for Metastatic Castration-resistant Prostate Cancer: A New-user Design in the French Nationwide Claims Database
Marine Gross-Goupil
Favorite
Gross, Nicholas

Teva Pharmaceutical Industries Ltd.
(P-143) Prescribing Patterns of Lipegfilgrastim in EU: A Retrospective Study
Nicholas Gross
Favorite
Grundmark, Birgitta

Uppsala Monitoring Centre, Sweden
(P-375) Remdesivir Safety Monitoring During the COVID-19 Pandemic: A Global Review of Adverse Drug Reaction (ADR) Reporting in Vigibase
Birgitta Grundmark
Favorite
Guenther, Geoffrey

Children's National Medical Center
(P-248) Modeling Parasite Clearance Curves in a Cohort to Compare Quinine and Artesunate for the Treatment of Pediatric Cerebral Malaria
Geoffrey Guenther
Favorite
Guerra Junior, Augusto

Federal University of Minas Gerais
(P-096) Comparative Clinical Effectiveness of Secuquinumabe and Anti-tnf Agents in the Treatment of Psoriasic Arthritis
Augusto Guerra Junior
Favorite
(P-394) Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
Augusto Guerra Junior
Favorite
Guerreiro, Jose

Centre for Health Evaluation & Research (CEFAR), National Association of Pharmacies (ANF)
(P-139) Consumption Patterns of Chronic Medication During the COVID-19 Pandemic in Portugal
Jose Guerreiro
Favorite
(P-418) Optimization of Prescription Patterns: A Response to Control High Pharmaceutical Expenditure
Jose Guerreiro
Favorite
Guertin, Jason

Département de Médecine Sociale et Préventive, Faculté de médecine, Université Laval, Montreal, Canada
(P-585) Association Between Oral Anticoagulants and Risk of Dementia in Patients with Non-valvular Atrial Fibrillation
Jason Guertin
Favorite
Gulmez, Sinem Ezgi

Ko� University School of Medicine
(P-448) Nsaids and Paracetamol-induced Hepatotoxicity: A Systematic Review and Meta-analysis of Observational Studies
Sinem Ezgi Gulmez
Favorite
Guo, Jeff

University of Cincinnati
(P-215) Safety Profile Analysis of Sunitinib and Dasatinib Protein Kinase Inhibitors Using FDA Adverse Event Reporting System (FAERS) Database
Jeff Guo
Favorite
(P-266) Effectiveness and Safety of Edoxaban and Warfarin in Nonvalvular Atrial Fibrillation Patients: A Meta-analysis of Real-world Studies
Jeff Guo
Favorite
Guo, Jianfei

James L. Winkle College of Pharmacy, University Of Cincinnati
(P-200) Safety Evaluation of Panobinostat, Ixazomib, Elotuzumab, and Daratumumab Using FDA Adverse Event Reporting System (FAERS) Database 2015 – 2020
Jianfei Guo
Favorite
Guo, Jingchuan

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(P-066) Trends in the Management of Primary Headache in US Emergency Departments: Analysis of 2007-2018 NHAMCS Data
Jingchuan Guo
Favorite
(P-288) Novel Glucose-lowering Agents and Cardiorenal Benefits: Absence of Racial/ethnic Diversity in Clinical Trials
Jingchuan Guo
Favorite
(P-386) Association Between Primary Care Provider Payment Models and Adherence to Anticoagulation in a Sample of Patients with Atrial Fibrillation
Jingchuan Guo
Favorite
Guo, Qixiang

Beijing chaoyang hospital, Capital medical university
(P-468) Biliary Toxicity of Immune Checkpoint Inhibitors: A Pharmacovigilance Study Through FDA Adverse Event Reporting System Database
Qixiang Guo
Favorite
Guo, Yutao

Department of Cardiology, Chinese PLA General Hospital, Beijing, China
(P-118) Understanding Oral Anticoagulant Preferences of Patients with Atrial Fibrillation in China and Willingness-to-pay: Evidence from a Discrete Choice Experiment
Yutao Guo
Favorite
Gupta, Niodita

AbbVie, Inc
(P-522) Early Parkinson’s Disease: Association of Baseline Fatigue, Pain and Sleep Disorders with Disease Progression
Niodita Gupta
Favorite
Gurubaran, Aatheep

Mu Sigma
(P-395) Evaluation of Drain Use During Total Knee Replacement Associated with Health Outcomes and Healthcare Utilization
Aatheep Gurubaran
Favorite
GU, Xinchun

The University of Manchester
(P-090) Classification of Gabapentinoids as Controlled Drugs Reduced Gabapentinoid Prescriptions in Primary Care in England
Xinchun GU
Favorite